Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
19.34 USD | -0.21% |
|
+15.98% | +77.15% |
24/06 | Edgewise Therapeutics, Inc.(NasdaqGS:EWTX) added to S&P Pharmaceuticals Select Industry Index | CI |
10/05 | Wedbush Raises Edgewise Therapeutics' PT to $31 From $26, Keeps Outperform Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+77.15% | 1.81B | |
+16.59% | 44.44B | |
-9.89% | 37.99B | |
+36.64% | 37.75B | |
+27.12% | 30.78B | |
-8.64% | 27.38B | |
+11.81% | 26.17B | |
+45.08% | 14.15B | |
+32.85% | 12.59B | |
-7.19% | 11.28B |
- Stock Market
- Equities
- EWTX Stock
- News Edgewise Therapeutics, Inc.
- RBC Raises Price Target on Edgewise Therapeutics to $32 From $28, Keeps Outperform, Speculative Risk